Gkountakos, A.; Centonze, G.; Vita, E.; Belluomini, L.; Milella, M.; Bria, E.; Milione, M.; Scarpa, A.; Simbolo, M.
Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance. Biomedicines 2022, 10, 277.
https://doi.org/10.3390/biomedicines10020277
AMA Style
Gkountakos A, Centonze G, Vita E, Belluomini L, Milella M, Bria E, Milione M, Scarpa A, Simbolo M.
Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance. Biomedicines. 2022; 10(2):277.
https://doi.org/10.3390/biomedicines10020277
Chicago/Turabian Style
Gkountakos, Anastasios, Giovanni Centonze, Emanuele Vita, Lorenzo Belluomini, Michele Milella, Emilio Bria, Massimo Milione, Aldo Scarpa, and Michele Simbolo.
2022. "Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance" Biomedicines 10, no. 2: 277.
https://doi.org/10.3390/biomedicines10020277
APA Style
Gkountakos, A., Centonze, G., Vita, E., Belluomini, L., Milella, M., Bria, E., Milione, M., Scarpa, A., & Simbolo, M.
(2022). Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance. Biomedicines, 10(2), 277.
https://doi.org/10.3390/biomedicines10020277
